Frequency Modulation Spectroscopy - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Frequency Modulation Spectroscopy
A Novel Nondestructive Approach for Measuring Moisture Activity in Pharmaceutical Samples


Pharmaceutical Technology



Figure 1: Principle and schematic of frequency modulation spectroscopy. Top figure (a) shows the frequency and intensity profile of a diode laser beam. Diagrams from left to right show an unmodulated, modulated with no absorption, and modulated with absorption by the upper sideband. Bottom figure (b) is a schematic diagram of an instrument for frequency modulation spectroscopy.
A less common approach involves capacitance measurements to obtain water activity results. A sensor made from a thin-film hygroscopic polymer relates the film capacitance to the headspace moisture content. Because this instrument relates an electrical signal to relative humidity, the sensor must be calibrated with known salt-solution relative humidity standards. In addition, for successful measurement, the sample and sensor must be at the same temperature. Although both of these instruments can be effectively applied to headspace moisture measurements, the nondestructive nature of frequency modulation spectroscopy (FMS) seemed to make the instrument ideal for exploration for examining the headspace moisture over pharmaceutical solids. The major shortcomings of the present techniques relate to the introduction of bias to the measurement and the inability to control measurement temperature over a wide range. Adding another sophisticated tool to the available arsenal of techniques to conduct critically important water activity measurements seemed to be worthwhile from the perspective of further refining the interface between measurement science and packaging research and development (7–9).

Fundamentals of frequency modulation spectroscopy


Figure 2: Frequency modulation signals from moisture absorption. The peak-to-peak amplitude of each spectrum is proportional to moisture concentration. The relative humidity is noted to the right of the 0% and 100% scan.
Water molecules in the gas phase absorb near infrared (NIR) light in a band of rotational transitions centered at 1400 nm. Absorbance measurements at this wavelength on typical NIR spectrometers using incoherent white-light sources lack the sensitivity to provide a useful measure of headspace moisture levels because of low-frequency lamp-intensity fluctuations. The measurement signal-to-noise (S/N) ratio can be vastly improved (100–10,000X), however, by laser-light sources and frequency modulation detection techniques (10–11). When a tunable diode laser is modulated using a radio frequency oscillator, the detection bandwidth can be shifted to higher frequency where intensity fluctuations, inherent to low frequency measurements, are minimized.

The frequency modulation spectroscopy measurement is conducted by frequency modulating a diode laser by superimposing a radio frequency oscillation, Ω, onto the diode injection current. The spectral output of a frequency modulated diode laser (see Figure 1) consists of a carrier frequency ωc and side band frequencies, ωc Ω. When the laser is scanned through the wavelength of moisture absorbance, the amount of light absorption, which is proportional to the concentration of the water molecules, is "written" into the side band frequencies by recording the difference in absorption between the two sidebands. The differential absorption information is recovered with phase-sensitive detection techniques. The demodulated absorption line shape is shown in Figure 2. The amount of light absorbed is directly proportional to the water concentration in the gas phase. The gaseous water density n is related to the peak-to-peak signal amplitude ΔI by Beer's law, which for a weakly absorbing molecule is given by:


ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
23%
Oversee medical treatment of patients in the US.
14%
Provide treatment for patients globally.
7%
All of the above.
47%
No government involvement in patient treatment or drug development.
9%
Jim Miller Outsourcing Outlook Jim MillerOutside Looking In
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerAdvances in Large-Scale Heterocyclic Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler New Era for Generic Drugs
Sean Milmo European Regulatory WatchSean MilmoTackling Drug Shortages
New Congress to Tackle Health Reform, Biomedical Innovation, Tax Policy
Combination Products Challenge Biopharma Manufacturers
Seven Steps to Solving Tabletting and Tooling ProblemsStep 1: Clean
Legislators Urge Added Incentives for Ebola Drug Development
FDA Reorganization to Promote Drug Quality
Source: Pharmaceutical Technology,
Click here